Department of Anesthesiology and Oncological Pain Medicine, Fukuyama City Hospital, Hiroshima, Japan.
Department of Intensive Care Medicine, Okayama University Hospital, Okayama, Japan.
J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3568-3573. doi: 10.1053/j.jvca.2021.05.024. Epub 2021 May 19.
Heparin resistance (HR), defined as a decrease in heparin responsiveness, can result in adverse events with prolonged duration of surgery. Although some clinical risk factors have been suggested, the relationship with the surgical diagnosis is unclear. The aim of present study was to elucidate the clinical predictors of HR including the surgical diagnosis.
This retrospective cohort study determined the incidence of HR (defined as activated clotting time [ACT] <400 seconds after 250-350 IU/kg of heparin administration) and heparin sensitivity index (HSI) was calculated from the rate of change in ACT per heparin dose. Preoperative demographic data, medication history, and laboratory data also were analyzed.
Single institution, tertiary care hospital.
Adult patients who underwent cardiovascular surgery with cardiopulmonary bypass between January 2012 and September 2018.
None.
Of 287 patients, 88 (30.7%) were classified as HR. In univariate analysis, infective endocarditis (IE), platelet count, and serum fibrinogen and albumin levels were associated with HR. After adjustment for baseline ACT and initial heparin dose, IE (odds ratio 4.57, [95% CI: 1.10-19.1]; p = 0.037) and albumin ≤3.5 g/dL (3.17, [1.46-6.93]; p = 0.004) were associated independently with HR. Patients with IE had significantly lower HSI than those with other diseases. All HR patients were treated with additional heparin, and 17 of them received human antithrombin-III concentrate.
Infective endocarditis and preoperative hypoalbuminemia were associated independently with HR. The optimal anticoagulation strategy for patients with these risk factors requires further investigations based on the authors' findings.
肝素抵抗(HR)定义为肝素反应性降低,可能导致手术时间延长的不良事件。尽管已经提出了一些临床危险因素,但与手术诊断的关系尚不清楚。本研究旨在阐明包括手术诊断在内的 HR 的临床预测因素。
本回顾性队列研究确定了 HR 的发生率(定义为在给予 250-350IU/kg 肝素后 ACT<400 秒),并根据 ACT 变化率计算肝素敏感性指数(HSI)每单位肝素剂量。还分析了术前人口统计学数据、用药史和实验室数据。
单机构、三级护理医院。
2012 年 1 月至 2018 年 9 月期间接受体外循环心血管手术的成年患者。
无。
在 287 例患者中,88 例(30.7%)被归类为 HR。在单因素分析中,感染性心内膜炎(IE)、血小板计数以及血清纤维蛋白原和白蛋白水平与 HR 相关。在调整基线 ACT 和初始肝素剂量后,IE(优势比 4.57,[95%CI:1.10-19.1];p=0.037)和白蛋白≤3.5g/dL(3.17,[1.46-6.93];p=0.004)与 HR 独立相关。患有 IE 的患者的 HSI 明显低于患有其他疾病的患者。所有 HR 患者均接受了额外的肝素治疗,其中 17 例患者接受了人抗凝血酶-III 浓缩物治疗。
感染性心内膜炎和术前低白蛋白血症与 HR 独立相关。根据作者的发现,需要进一步研究这些危险因素患者的最佳抗凝策略。